midomafetamine
midomafetamine is a pharmaceutical drug with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
60.0%
6 of 10 finished
40.0%
4 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Dose Optimization of MDMA-Assisted Therapy for PTSD
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Evaluation of MDMA on Startle Response
Clinical Trials (12)
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Dose Optimization of MDMA-Assisted Therapy for PTSD
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Evaluation of MDMA on Startle Response
A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD
Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
Food Effects on Bioavailability of MDMA in Healthy Volunteers
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12